Nintendo   Report issue

For profit
Founded: Kyoto Japan (1889)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT00932685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Nintendo of North America

Active Ingredients

Drugs in Other Trials (1)

midazolam (versed) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1